About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 251846, 9 pages
http://dx.doi.org/10.1155/2013/251846
Research Article

The Role of Bone Marrow Mesenchymal Stem Cells in the Treatment of Acute Liver Failure

1Department of Infectious Diseases, First Affiliated Hospital of Xinjiang Medical University, Xinjiang 830011, China
2State Key Laboratory Incubation Base of Xinjiang Major Diseases Research, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830054, China
3Key Laboratory of Xinjiang Medical Animal Model Research, Xinjiang 830011, China
4Xinjiang University, Urumqi, Xinjiang 830011, China

Received 30 April 2013; Revised 13 September 2013; Accepted 14 September 2013

Academic Editor: Dimitrios P. Bogdanos

Copyright © 2013 Shufang Yuan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. M. Stutchfield, S. J. Forbes, and S. J. Wigmore, “Prospects for stem cell transplantation in the treatment of hepatic disease,” Liver Transplantation, vol. 16, no. 7, pp. 827–836, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Puppi and A. Dhawan, “Human hepatocyte transplantation overview,” Methods in Molecular Biology, vol. 481, pp. 1–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Suchánek, B. Visek, T. Soukup et al., “Stem cells from human exfoliated deciduous teeth–isolation, long term cultivation and phenotypical analysis,” Acta Medica, vol. 53, no. 2, pp. 93–99, 2010. View at Scopus
  4. A. Bajek, J. Olkowska, and T. Drewa, “Mesenchymal stem cells as a therapeutic tool in tissue and organ regeneration,” Postepy Higieny i Medycyny Doswiadczalnej, vol. 65, pp. 124–132, 2011. View at Scopus
  5. M. Muraca, “Evolving concepts in cell therapy of liver disease and current clinical perspectives,” Digestive and Liver Disease, vol. 43, no. 3, pp. 180–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K.-A. Cho, S.-Y. Ju, S. J. Cho et al., “Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow,” Cell Biology International, vol. 33, no. 7, pp. 772–777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Rust and G. J. Gores, “Apoptosis and liver disease,” American Journal of Medicine, vol. 108, no. 7, pp. 567–574, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. S. K. Tschoeke, A. Oberholzer, and L. L. Moldawer, “Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis,” Critical Care Medicine, vol. 34, no. 4, pp. 1225–1233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. T. Carrascal, L. Mendoza, M. Valcárcel et al., “Interleukin-18 binding protein reduces B16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium,” Cancer Research, vol. 63, no. 2, pp. 491–497, 2003. View at Scopus
  10. S. Finotto, J. Siebler, M. Hausding et al., “Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo,” Gut, vol. 53, no. 3, pp. 392–400, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Mariño and J. E. Cardier, “Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95),” Cytokine, vol. 22, no. 5, pp. 142–148, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Bianco, P. G. Robey, and P. J. Simmons, “Mesenchymal stem cells: revisiting history, concepts, and assays,” Cell Stem Cell, vol. 2, no. 4, pp. 313–319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Le Blanc, F. Frassoni, L. Ball et al., “Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study,” The Lancet, vol. 371, no. 9624, pp. 1579–1586, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. S. Freedman, A. Bar-Or, H. L. Atkins et al., “The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the international MSCT study group,” Multiple Sclerosis, vol. 16, no. 4, pp. 503–510, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Kisseleva, E. Gigante, and D. A. Brenner, “Recent advances in liver stem cell therapy,” Current Opinion in Gastroenterology, vol. 26, no. 4, pp. 395–402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. C. Popp, P. Renner, E. Eggenhofer et al., “Mesenchymal stem cells as immunomodulators after liver transplantation,” Liver Transplantation, vol. 15, no. 10, pp. 1192–1198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Sordi and L. Piemonti, “Therapeutic plasticity of stem cells and allograft tolerance,” Cytotherapy, vol. 13, no. 6, pp. 647–660, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Liu, Z.-D. Liu, N. Wu et al., “Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats,” Liver Transplantation, vol. 15, no. 9, pp. 1092–1100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Muraca, “Evolving concepts in cell therapy of liver disease and current clinical perspectives,” Digestive and Liver Disease, vol. 43, no. 3, pp. 180–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. A. Dinarello, “Interleukin-18 and the pathogenesis of inflammatory diseases,” Seminars in Nephrology, vol. 27, no. 1, pp. 98–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. A. Dinarello, “Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process,” American Journal of Clinical Nutrition, vol. 83, no. 2, pp. 447–455, 2006. View at Scopus
  22. T.-B. Lee, Y.-D. Min, S.-C. Lim et al., “Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells,” Journal of Gastroenterology and Hepatology, vol. 17, no. 1, pp. 32–38, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. H. Shaw, T. Reimer, Y. G. Kim, and G. Nunez, “NOD-like receptors (NLRs): bona fide intracellular microbial sensors,” Current Opinion in Immunology, vol. 20, no. 4, pp. 377–382, 2008. View at Publisher · View at Google Scholar
  24. J.-C. Sirard, C. Vignal, R. Dessein, and M. Chamaillard, “Nod-like receptors: cytosolic watchdogs for immunity against pathogens,” PLoS Pathogens, vol. 3, no. 12, article e152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Ghayur, S. Banerjee, M. Hugunin et al., “Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production,” Nature, vol. 386, no. 6625, pp. 619–623, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Okuyama, B. Krishnamachary, Y. F. Zhou, H. Nagasawa, M. Bosch-Marce, and G. L. Semenza, “Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1,” Journal of Biological Chemistry, vol. 281, no. 22, pp. 15554–15563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. K.-A. Cho, S.-Y. Ju, S. J. Cho et al., “Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow,” Cell Biology International, vol. 33, no. 7, pp. 772–777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Hou, X. Zhang, T. Tang, K. Dai, and R. Ge, “Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1,” Biotechnology Letters, vol. 31, no. 8, pp. 1183–1189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C.-Y. Lin, Y.-H. Chang, K.-J. Lin et al., “The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells,” Biomaterials, vol. 31, no. 12, pp. 3222–3230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Parekkadan, D. Van Poll, K. Suganuma et al., “Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure,” PLoS One, vol. 2, no. 9, article e941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Liu, D. S. Dulchavsky, X. Gao et al., “Wound repair by bone marrow stromal cells through growth factor production,” Journal of Surgical Research, vol. 136, no. 2, pp. 336–341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Dinant, R. L. Veteläinen, S. Florquin, A. K. van Vliet, and T. M. van Gulik, “IL-10 Attenuates hepatic I/R injury and promotes hepatocyte proliferation,” Journal of Surgical Research, vol. 141, no. 2, pp. 176–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Robert Schwartz, Morayma Reyes, Lisa Koodie et al., “Multipotent 8duh pmgenitor cells from bone marrow differentiate into functional hepatocyte-like ceH8,” Journal of Clinical Investigation, vol. 109, no. 10, pp. 129l–1302, 2002. View at Publisher · View at Google Scholar
  34. J. Li, L. Zhang, J. Xin et al., “Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs,” Hepatology, vol. 56, no. 3, pp. 1044–1052, 2012. View at Publisher · View at Google Scholar